elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Papers
Communities
Lab
API & MCP
Pricing
Log in
Sign up
Home
/
Subjects
/
Erythema
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Erythema
RIS
0.003
(Research Intensity Score)
Papers
462
Top papers
New Perspectives on Titanium Dioxide and Zinc Oxide as Inorganic UV Filters: Advances, Safety, Challenges, and Environmental Considerations
2025 · 56 citations
Signaling pathways and targeted therapy for rosacea
2024 · 47 citations
Recent advances in the mechanisms, current treatment status, and application of multifunctional biomaterials for radiation-induced skin injury
2025 · 39 citations
Photoprotection beyond ultraviolet radiation: A review of tinted sunscreens
2020 · 204 citations
Exploratory clinical trial on the safety and bactericidal effect of 222-nm ultraviolet C irradiation in healthy humans
2020 · 163 citations
Newest papers
Clinical response and time to improvement with 308-nm excimer laser therapy in scarring alopecia: a retrospective cohort study
2026 · 1 citations
Excimer 308-nm laser for the treatment of frontal fibrosing alopecia: an observational study in 30 patients
2026 · 1 citations
Radiofrequency Microneedling for Facial Rejuvenation: A Systematic Review
2026 · 1 citations
Ultraviolet radiation and mitochondrial bioenergetic effects by reactive oxygen species production
2026 · 1 citations
Acupuncture for nummular eczema of the lower legs in an older adult: a case report
2026
A sample from the 100 top papers behind Erythema.
Create a free account to browse them all →
Erythema's history
Research intensity over time
Explore Erythema's full history
Hover any year for its value and switch resolutions with a free account. Personal adds monthly detail and the historical-intensity (HRI) line.
Create a free account
Already have an account?
Log in
to explore the data.
Close ✕
Erythema's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link